Ashok K. Patel

Dr. Ashok K. Patel

Internal Medicine
6320 Wedgwood Road North, 
Maple Grove, MN 
Accepting New Patients
Offers Telehealth
44 Years of Experience
6320 Wedgwood Road North, 
Maple Grove, MN 

Overview

Ashok Patel is a primary care provider, practicing in Internal Medicine in Maple Grove, Minnesota. He has been practicing medicine for over 44 years.

His clinical expertise encompasses Migraine, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Hypertension.

Dr. Patel is board certified in Internal Medicine: American Board Of Internal Medicine, 1986 and Geriatric Medicine: American Board Of Internal Medicine, 1990. He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 17 clinical trials. Dr. Patel is currently accepting new patients.

Graduate Year

1982

Specialties

Internal Medicine

Licenses

Geriatric Medicine in MN

Board Certifications

Internal Medicine: American Board Of Internal Medicine, 1986
Geriatric Medicine: American Board Of Internal Medicine, 1990

Hospital Affiliations

M Health Fairview University Of Mn Medical Center

Languages Spoken

English
Hindi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Sanford Health
  • HMO
  • PPO
SelectHealth
  • HMO
  • POS
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

M Health Fairview Clinic Bass Lake
6320 Wedgwood Road North, Maple Grove, MN 55311

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Terminated
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Terminated
Publish Date: June 25, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3451838 in Adults With Treatment-Resistant Migraine
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3451838 in Adults With Treatment-Resistant Migraine
Enrollment Status: Completed
Publish Date: November 28, 2023
Intervention Type: Drug
Study Drug: LY3451838
Study Phase: Phase 2
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost
A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost
Enrollment Status: Completed
Publish Date: July 11, 2022
Intervention Type: Drug
Study Drug: Oral Fasudil
Study Phase: Phase 2
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: July 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study
Enrollment Status: Completed
Publish Date: July 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

2 Total Publications

Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adults with treatment-resistant migraine.
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adults with treatment-resistant migraine.
Journal: Cephalalgia : an international journal of headache
Published: August 21, 2025
Similar Doctors
Expertise in
9
conditions
Dr. Kristine E. Ensrud
Internal Medicine
Expertise in
9
conditions
Dr. Kristine E. Ensrud
Internal Medicine

Minneapolis Veterans Administration Hospital

1 Veterans Dr, 
Minneapolis, MN 
 (20.1 miles away)
612-725-2158
Languages Spoken:
English
See accepted insurances

Kristine Ensrud is a primary care provider, practicing in Internal Medicine in Minneapolis, Minnesota. Dr. Ensrud is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Menopause, Hormone Replacement Therapy (HRT), and Hip Replacement.

Expertise in
15
conditions
Dr. Nedaa Skeik
Internal Medicine
Expertise in
15
conditions
Dr. Nedaa Skeik
Internal Medicine

Allina Health Minneapolis Heart Institute-Centennial Lakes (Edina)

7373 France Ave S Ste 300, 
Edina, MN 
 (18.4 miles away)
612-863-6800
Languages Spoken:
English, Arabic, Spanish, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Nedaa Skeik is a primary care provider, practicing in Internal Medicine in Edina, Minnesota. Dr. Skeik is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Venous Insufficiency, Varicose Veins, Fibromuscular Dysplasia (FMD), Thrombectomy, and Tissue Biopsy. Dr. Skeik is currently accepting new patients.

Expertise in
11
conditions
Dr. Andrew R. Hart
Internal Medicine
Expertise in
11
conditions
Dr. Andrew R. Hart
Internal Medicine

North Memorial Health Clinic - Minnetonka

15450 Highway 7, 
Minnetonka, MN 
 (13.0 miles away)
763-310-1534
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrew Hart is a primary care provider, practicing in Internal Medicine in Minnetonka, Minnesota. Dr. Hart is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Diabetic Nephropathy, Sitosterolemia, Type 2 Diabetes (T2D), and High Cholesterol. Dr. Hart is currently accepting new patients.

Frequently Asked Questions about Dr. Ashok K. Patel

How do I make an appointment with Dr. Ashok K. Patel?

You can book an appointment with Dr. Ashok K. Patel by calling their office at 763-268-0400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ashok K. Patel a top-rated expert for Migraine?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ashok K. Patel is classified as an Experienced expert for Migraine, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ashok K. Patel specialize in?

While Dr. Ashok K. Patel is a Internal Medicine, they have specific expertise in Migraine, Glucocorticoid-Remediable Aldosteronism, and Hypertension. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Ashok K. Patel participate in research or clinical trials?

Yes. Dr. Ashok K. Patel has published 2 articles and abstracts on conditions like Migraine. You can view a list of Dr. Ashok K. Patel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ashok K. Patel accept my insurance?

Dr. Ashok K. Patel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 763-268-0400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
        View All 56 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile